FDA Approves Sorilux for Adolescent Plaque Psoriasis
The US Food and Drug Administration (FDA) has approved SORILUX (calcipotriene) Foam, 0.005% in adolescents.
The US Food and Drug Administration (FDA) has approved SORILUX (calcipotriene) Foam, 0.005% in adolescents.
MedStar Georgetown University Hospital has reported a robotic nipple-sparing mastectomy performed through a single hidden incision that combined immediate reconstruction, sentinel lymph node biopsy, and a nerve-sparing technique designed to help preserve breast sensation.